cefixime has been researched along with Neoplasms in 5 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
"Without cefixime, diarrhea was dose limiting at irinotecan 45 mg/m2/d." | 5.12 | Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. ( Billups, C; Crews, KR; Daw, NC; Dome, JS; Furman, WL; Gajjar, AJ; Houghton, PJ; Panetta, JC; Patrick, CC; Rodriguez-Galindo, C; Santana, VM; Stewart, CF; Wu, J, 2006) |
"The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
"Febrile neutropenia is a heterogeneous condition." | 2.69 | Oral administration of cefixime to lower risk febrile neutropenic children with cancer. ( Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA, 2000) |
"Shigella infection was diagnosed in 45 cancer patients." | 1.43 | Shigella infections: A two year experience in cancer patients. ( Mahboob, A; Nazeer, SH; Nizammudin, S; Raza, A; Sultan, F, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raza, A | 1 |
Mahboob, A | 1 |
Nizammudin, S | 1 |
Nazeer, SH | 1 |
Sultan, F | 1 |
Furman, WL | 1 |
Crews, KR | 1 |
Billups, C | 1 |
Wu, J | 1 |
Gajjar, AJ | 1 |
Daw, NC | 1 |
Patrick, CC | 2 |
Rodriguez-Galindo, C | 1 |
Stewart, CF | 1 |
Dome, JS | 1 |
Panetta, JC | 1 |
Houghton, PJ | 1 |
Santana, VM | 2 |
Paganini, HR | 1 |
Sarkis, CM | 1 |
De Martino, MG | 1 |
Zubizarreta, PA | 1 |
Casimir, L | 2 |
Fernandez, C | 2 |
Armada, AA | 1 |
Rodriguez-Brieshcke, MT | 1 |
Debbag, R | 2 |
Shenep, JL | 1 |
Flynn, PM | 1 |
Baker, DK | 1 |
Hetherington, SV | 1 |
Hudson, MM | 1 |
Hughes, WT | 1 |
Roberson, PK | 1 |
Sandlund, JT | 1 |
Sixbey, JW | 1 |
Slobod, KS | 1 |
Paganini, H | 1 |
Rodriguez-Brieshcke, T | 1 |
Zubizarreta, P | 1 |
Latella, A | 1 |
Firpo, V | 1 |
Armada, A | 1 |
Cáceres, E | 1 |
4 trials available for cefixime and Neoplasms
Article | Year |
---|---|
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Cefixime; | 2006 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Chi | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
1 other study available for cefixime and Neoplasms
Article | Year |
---|---|
Shigella infections: A two year experience in cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Comorbidit | 2016 |